Co-Authors
This is a "connection" page, showing publications co-authored by VALERAE O LEWIS and CHRISTINA LYNN ROLAND.
Connection Strength
2.024
-
Antibiotic Prophylaxis of Surgical Site Infections-A Double-edged Sword for Oncology Patients? JAMA Oncol. 2022 03 01; 8(3):340-342.
Score: 0.827
-
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer. 2024 Apr; 5(4):625-641.
Score: 0.237
-
Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature. Ann Surg Oncol. 2023 Feb; 30(2):958-967.
Score: 0.216
-
Multidisciplinary Approach to Hemipelvectomy for Pelvic Sarcomas. JBJS Rev. 2022 05 01; 10(5).
Score: 0.209
-
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913.
Score: 0.163
-
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes. Cancer. 2024 Aug 27.
Score: 0.061
-
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res. 2023 05 01; 29(9):1708-1718.
Score: 0.056
-
ASO Author Reflections: Variability in Management of Sarcoma Lymph Node Metastases. Ann Surg Oncol. 2023 06; 30(6):3677-3678.
Score: 0.055
-
Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Ann Surg Oncol. 2023 Jun; 30(6):3668-3676.
Score: 0.055
-
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2022 12; 23(12):1547-1557.
Score: 0.054
-
Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies. Cancer. 2020 07 15; 126(14):3265-3273.
Score: 0.046
-
Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control. Am J Clin Oncol. 2019 10; 42(10):744-748.
Score: 0.044